Skip to main content

Advertisement

Log in

The effects of raloxifene hydrochloride on ocular hemodynamics and visual function

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Objective To assess the comprehensive effects of raloxifene hydrochloride on retinal, choroidal and retrobulbar hemodynamics and on visual function in post-menopausal women. Design Twenty-four post-menopausal women (age 55 ± 3.8 years) were recruited for this cross-sectional study: 12 received placebo and 12 received raloxifene hydrochloride 60 mg once a day for 3 months. Baseline measurements of both groups included heart rate (HR), blood pressure (BP), visual acuity, contrast sensitivity and intraocular pressure (IOP) for both eyes. A comprehensive ocular blood flow (OBF) assessment was obtained for each patient in a randomly chosen study eye. Retinal blood flow data was obtained using confocal scanning laser Doppler flowmetry [Heidelberg Retinal Flowmeter (HRF)]. Color Doppler imaging (CDI) was used to assess retrobulbar hemodynamics in the ophthalmic, central retinal, short nasal and temporal posterior ciliary arteries. Baseline vision and hemodynamics in post-menopausal subjects were compared using paired Student’s t tests, and the percentage change in baseline versus 3-month parameters was analyzed. Results There were no statistically significant differences between 3 months of raloxifene therapy and placebo in terms of age, HR, arterial or mean BP, visual acuity, contrast sensitivity, IOP or retinal or retrobulbar blood flow. Conclusion Raloxifene therapy at 60 mg/day had no clinically significant impact on BP, IOP or OBF in post-menopausal women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Muchmore DB (2000) Raloxifene: a selective estrogen receptor modulator (SERM) with multiple target system effects. Oncologist 5:388–392

    Article  PubMed  CAS  Google Scholar 

  2. Raloxifene (1997) Package insert. Eli Lilly and Company, Indianapolis

  3. Kleinert H, Wallerath T, Euchenhofer C, Ihrig-Biedert I, Li H, Forstermann U (1998) Estrogens increase transcription of the human endothelial NO synthase gene: analysis of the transcription factors involved. Hypertension 31:582–588

    PubMed  CAS  Google Scholar 

  4. Khorram O, Garthwaite M, Magness RR (1999) Endometrial and myometrial expression of nitric oxide synthase isoforms in pre- and postmenopausal women. J Clin Endocrinol Metab 84:2226–2232

    Article  PubMed  CAS  Google Scholar 

  5. Wassmann S, Laufs U, Stamenkovic D et al (2002) Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production. Circulation 105:2083–2091

    Article  PubMed  CAS  Google Scholar 

  6. Sarrel PM, Nawaz H, Chan W, Fuchs M, Katz DL (2003) Raloxifene and endothelial function in healthy postmenopausal women. Am J Obstet Gynecol 188:304–309

    Article  PubMed  CAS  Google Scholar 

  7. Saitta A, Altavilla D, Cucinotta D et al (2001) Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin–1 levels, and endothelium-dependent vasodilation in postmenopausal women. Arterioscler Thromb Vasc Biol 21:1512–1519

    Article  PubMed  CAS  Google Scholar 

  8. Lang Y, Lang N, Ben-Ami M, Garzozi H (2002) The effects of hormone replacement therapy (HRT) on the human eye. Harefuah 141:287–291

    PubMed  Google Scholar 

  9. Harris A, Harris M, Biller J et al (2000) Aging affects the retrobulbar circulation differently in women and men. Arch Ophthalmol 118:1076–1080

    PubMed  CAS  Google Scholar 

  10. Centofanti M, Migliardi R, Bonini S et al (2002) Pulsatile ocular blood flow during pregnancy. Eur J Ophthalmol 12:276–280

    PubMed  CAS  Google Scholar 

  11. Toker E, Yenice O, Akpinar I, Aribal E, Kazokoglu H (2003) The influence of sex hormones on ocular blood flow in women. Acta Ophthalmol Scand 81:617–624

    Article  PubMed  CAS  Google Scholar 

  12. Belfort MA, Saade GR, Snabes M et al (1995) Hormonal status affects the reactivity of the cerebral vasculature. Am J Obstet Gynecol 172:1273–1278

    Article  PubMed  CAS  Google Scholar 

  13. Harris-Yitzhak M, Harris A, Ben-Reael Z, Zarfati D, Garzozi HJ, Martin BJ (2000) Estrogen-replacement therapy: effects on retrobulbar hemodynamics. Am J Ophthalmol 129:623–628

    Article  PubMed  CAS  Google Scholar 

  14. Atalay E, Karaali K, Akar M et al (2005) Early impact of hormone replacement therapy on vascular hemodynamics detected via ocular colour Doppler analysis. Maturitas 50:282–288

    Article  PubMed  CAS  Google Scholar 

  15. van Baal WM, Kenemans P, Stehouwer CD, Peters-Muller ER, van Vugt JM, van der Mooren MJ (1999) Sequentially combined hormone replacement therapy reduces impedance to flow within the uterine and central retinal arteries in healthy postmenopausal women. Am J Obstet Gynecol 181:1365–1373

    Article  PubMed  Google Scholar 

  16. Battaglia C, Mancini F, Regnani G, Persico N, Volpe A, De Aloysio D (2004) Hormone therapy and ophthalmic artery blood flow changes in women with primary open-angle glaucoma. Menopause 11:69–77

    Article  PubMed  Google Scholar 

  17. Altinta O, Caglar Y, Yuksel N, Demirci A, Karabas L (2004) The effects of menopause and hormone replacement therapy on quality and quantity of tear, intraocular pressure and ocular blood flow. Ophthalmologica 218:120–129

    Article  Google Scholar 

  18. Kagemann L, Harris A, Chung HS, Evans D, Buck S, Martin B (1998) Heidelberg retinal flowmetry: factors affecting blood flow measurement. Br J Ophthalmol 82:131–136

    Article  PubMed  CAS  Google Scholar 

  19. Harris A, Williamson T, Martin B, Shoemaker J, Sergott R, Spaeth G, Katz J (1995) Test/retest reproducibility of color Doppler imaging assessment of blood flow velocity in orbital vessels. J Glaucoma 4:281−286

    Google Scholar 

  20. Cagnacci A, Zanni AL, Volpe A (2003) Administration of raloxifene does not influence 24 hour ambulatory blood pressure of postmenopausal women with osteopenia: a double blind placebo-controlled study. Am J Obstet Gynecol 188:1278–1282

    Article  PubMed  CAS  Google Scholar 

  21. Morgante G, Delia A, Musacchio MC, Severi FM, Petraglia F, De Leo V (2006) Effects of raloxifene therapy on plasma rennin and aldosterone levels and blood pressure in postmenopausal women. Gynecol Endocrinol 22:376–380

    Article  PubMed  CAS  Google Scholar 

  22. Colacurci N, Manzella D, Fornaro F, Carbonella M, Paolisso G (2003) Endothelial function and menopause: effects of raloxifene administration. J Clin Endocrinol Metab 88:2135–2140

    Article  PubMed  CAS  Google Scholar 

  23. Cagnacci A, Arangino S, Renzi A, Zanni AL, Volpe A (2003) Raloxifene does not influence flow-mediated endothelium-dependent and endothelium-independent vasodilatation of osteopenic postmenopausal women. Am J Obstet Gynecol 188:313–317

    Article  PubMed  CAS  Google Scholar 

  24. Figtree GA, Lu Y, Webb CM, Collins P (1999) Raloxifene acutely relaxes rabbit coronary arteries in vitro by an estrogen receptor-dependent and nitric oxide-dependent mechanism. Circulation 100:1095–1101

    PubMed  CAS  Google Scholar 

  25. Zoma WD, Baker RS, Clark KE (2000) Coronary and uterine vascular responses to raloxifene in the sheep. Am J Obstet Gynecol 182:521–528

    Article  PubMed  CAS  Google Scholar 

  26. Venkov CD, Rankin AB, Vaughan DE (1996) Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation 94:727–733

    PubMed  CAS  Google Scholar 

  27. Ceresini G, Marchini L, Rebecchi I et al (2003) Effects of raloxifene on carotid blood flow resistance and endothelium-dependent vasodilation in postmenopausal women. Atherosclerosis 167:121–127

    Article  PubMed  CAS  Google Scholar 

  28. Harris A, Jonescu-Cuypers C, Martin B, Kagemann L, Zalish M, Garzozi HJ (2001) Simultaneous management of blood flow and IOP in glaucoma. Acta Ophthalmol Scand 79:336–341

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by a research study grant from Eli Lilly Pharmaceuticals, Indianapolis, IN and in part by an unrestricted grant from Research to Prevent Blindness, New York, NY.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alon Harris.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Siesky, B., Harris, A., Kheradiya, N. et al. The effects of raloxifene hydrochloride on ocular hemodynamics and visual function. Int Ophthalmol 29, 225–230 (2009). https://doi.org/10.1007/s10792-008-9224-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-008-9224-4

Keywords

Navigation